About Us
A message from Inovio's President & CEO
At Inovio, we're seeking to help patients by improving their quality of life through innovative research. Our vision is to address cancers and chronic infectious diseases by providing a safe and effective DNA delivery method for next-generation vaccines — DNA vaccines — for preventive and therapeutic purposes.
DNA vaccines potentially represent a multi-billion-dollar business opportunity. We believe that Inovio's strong intellectual property and proprietary technology relating to electroporation-based DNA delivery may play a pivotal role in enabling delivery and enhancing the potency of this new generation of vaccines. We are committed to playing a leadership role in advancing the development and potential commercialization of these promising technologies.
Thank you for your interest in Inovio Biomedical.
Avtar Dhillon, MD
President & CEO
Mission & Values
Mission
Inovio's mission is to fulfill critical unmet medical needs in the treatment of cancer and chronic infectious diseases by striving to be a leading biotechnology company and creating novel therapeutic products that treat diseases and improve people's lives.
Leadership Strategy
We will accomplish our mission through technological leadership, product-oriented research, superior manufacturing, and commercial strategies that create and expand markets.
Ethical Standards
We adhere to the highest legal and ethical principles in the conduct of all aspects of our business. We are committed to adhering to proven standards of financial and operational performance.
Values
Our purpose is to find solutions to fulfill critical unmet needs in the treatment of cancer and other diseases. Because cancer and other diseases do not wait for solutions, we are driven by a sense of urgency. As a result, our environment is intense, challenging, and focused on creating value for those who use our products and delivering sustained overall growth for those who invest in our company.
Quality
Our goal at Inovio is to develop highly innovative and clinically effective products; develop cost effective internal controls, including quality systems; and promote overall growth of the company and maximize shareholder value.